Olon officially announces that the DMF of UMECLIDINIUM BROMIDE has been submitted to FDA under GDUFA procedure.
Umeclidinium Bromide is a high potent API with indication for Chronic Obstructive Pulmonary Disease (COPD), Chronic Bronchitis, Emphysema.
Olon is the only manufacturer in the European Union.